|Assessment Status||Rapid Review Complete|
|Indication||For the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.|
|Rapid review commissioned||15/01/2018|
|Rapid review completed||06/02/2018|
|Rapid review outcome||Full Pharmacoeconomic Evaluation Recommended|
The HSE has approved reimbursement following a price negotiation February 2019.